IGXT =MCap $33 M--FDA DECISION for Migraine Oral-film on March 26 and Launch of Cannabis Products by partner Tilray also expected during this Quarter =500% UPSIDE POTENTIAL ..
Cannabis-Infused VersaFilm® Remains on Track for Commercial Launch in Q1-2020
IntelGenx Continues to Make Preparations Ahead of RIZAPORT® PDUFA Goal Date of March 26, 2020
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.